Vanguard Personalized Indexing Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$966K Buy
47,072
+3,398
+8% +$77.8K 0.01% 1016
2026
Q1
$962K Buy
43,674
+7,936
+22% +$138K 0.01% 949
2025
Q4
$421K Buy
35,738
+1,748
+5% +$22.4K ﹤0.01% 1328
2025
Q3
$539K Buy
33,990
+610
+2% +$8.85K 0.01% 1211
2025
Q2
$382K Buy
33,380
+7,827
+31% +$88.2K ﹤0.01% 1327
2025
Q1
$346K Buy
25,553
+8,235
+48% +$137K 0.01% 1280
2024
Q4
$293K Sell
17,318
-5,804
-25% -$113K ﹤0.01% 1345
2024
Q3
$470K Buy
23,122
+9,020
+64% +$184K 0.01% 1121
2024
Q2
$318K Buy
14,102
+1,803
+15% +$47.2K 0.01% 1245
2024
Q1
$323K Buy
12,299
+1,772
+17% +$50.5K 0.01% 1237
2023
Q4
$332K Sell
10,527
-807
-7% -$21.9K 0.01% 1183
2023
Q3
$318K Sell
11,334
-5,272
-32% -$181K 0.01% 1097
2023
Q2
$613K Buy
16,606
+7,286
+78% +$222K 0.02% 802
2023
Q1
$279K Buy
+9,320
New +$307K 0.01% 1147
2022
Q3
Sell
-6,678
Closed -$214K 1241
2022
Q2
$214K Buy
+6,678
New +$246K 0.01% 1120

Other funds holding CC

Vanguard Personalized Indexing Management's CC Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Chemours (CC) stake by 7.8% in Q2 2026, buying an estimated $77.8K and bringing the position to 47,072 shares worth $966K. The position accounts for 0.01% of the portfolio, ranked #1016.

Vanguard Personalized Indexing Management first reported a position in CC in Q2 2022 and has held it in 15 quarters since. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Vanguard Personalized Indexing Management held 47,072 shares of Chemours worth $966K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 3,398 Chemours shares in Q2 2026, an estimated $77.8K.
  • Chemours made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1016 holding.
  • Vanguard Personalized Indexing Management first reported a position in Chemours in Q2 2022 and has held it in 15 quarters since.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.